Introduction
Psoriasis is an ancient and universal inflammatory disease, initially described at the beginning of medicine in the Corpus Hippocraticum. Hippocrates used the term psora, meaning 'to itch'. For centuries psoriasis was described as a variant of leprosy and was regarded as contagious until Von Hebra identified it as a distinct disease entity. 1 Psoriasis (OMIM 177900) is defined as a common inflammatory skin disorder of unknown etiology. 2 This chronic skin disorder is supposed to be a T-cell-mediated autoimmune disease with similarities to other complex autoimmune disorders (AIDs) such as rheumatoid arthritis, Crohn's disease and diabetes. The resemblances of psoriasis to other AIDs are the distinct role of genetic and environmental factors, variable age of onset, the great variability of the tissue reaction with different degrees of activity, extent of body involvement and frequency of relapses. In contrast to other organ-specific AIDs, which demonstrate an increasing prevalence rate, no significant changes in incidence rates are reported in psoriasis. This fact indicates that perhaps the environmental influence on the pathogenesis of psoriasis is less important than it is on the other autoimmune conditions mentioned above. 3 The most potent genetic influence on susceptibility to several AIDs is the major histocompatibility complex (MHC). The highest risk to susceptibility to psoriasis has also been reported for a region located on the short arm of chromosome 6. In contrast to other AIDs that are mostly linked to a certain class II human leukocyte antigen (HLA) alleles, psoriasis is the only known chronic inflammatory disease that has a strong association with a region encoding HLA-C and specifically with the HLA-Cw6 allele. 4, 5 The susceptibility region in chromosome 6 (PSORS1-psoriasis susceptibility 1) has refined to an approximately B300 kb region around HLA-C gene and contains several candidate genes including HLA-C, octamer transcription factor-3 (OTF3), transcription factor-19 (TCF19), corneodesmosin (CDSN) and a-helix coiled-coil rod homolog (HCR) genes. [6] [7] [8] [9] In addition, several non-MHC psoriasis susceptibility loci (1q21, 16q and 17q) associate with different AIDs such as systemic lupus erythematosus, rheumatoid arthritis, Crohn's disease and diabetes. 10 This provides support for the hypothesis that susceptibility to different AIDs may be driven by the same susceptibility genes and immunopathways. Gene expression studies on involved psoriatic skin, uninvolved psoriatic skin and normal skin applying the Affimetrix Gene Chips identified 1338 genes with potential roles in the pathogenesis of psoriasis. 11 Many of these identified genes are known to be involved in immune response and proliferation.
Interleukin (IL)-10 gene cluster locates in a 200 kb region of chromosome 1 within the q31-32 locus and holds four genes: IL-10, IL-19, IL-20 and IL-24.
12-15 The relevance of IL-10 gene polymorphisms has been demonstrated by their involvement in determining the susceptibility and/or the severity for a number of immune inflammatory diseases including rheumatoid arthritis, 16 inflammatory bowel disease, 17 systemic lupus erythematosus 18 and severe asthma. 19 We demonstrated previously that IL-10 promoter polymorphisms influence clinical course of plaque-type psoriasis. 20 Hensen et al 21 observed the protective effect of the microsatellite marker IL-10.G9 allele 3 from the IL-10 promoter region to familial psoriasis.
The IL-10 family cytokines IL-19, IL-20 and IL-24 form an individual subgroup named as IL-19 subfamily. 22 The IL-19 subfamily is characterized by their amino-acid homologies and by the fact that all the members of this subfamily are able to bind to and signal through the IL-20 receptor beta chain. Binding of the IL-19 subfamily members to the IL-20 receptor activates the STAT pathway in cytokine-responsive cells. 23, 24 The role of IL-19 and IL-20 in the function of epidermis and in the pathogenesis of psoriasis has been established. 13, 25, 26 Recent studies also indicate that the third member of the IL-19 subfamily-IL-24 (MDA-7)-might have a pathogenic role in psoriasis. The rat ortholog of the human IL-24 named as c49a has been found in fibroblastlike cells during skin wound healing. 27 Elevated expression of c49a gene before and during the proliferation phase of repairing indicate that c49a might promote cell proliferation. Several investigators have postulated that psoriatic plaques represent persistent reactions of wound healing. 28, 29 Moreover, the expression of IL-24 mRNA has been found in mononuclear cells located in the papillae and in the dense inflammatory areas in the subpapillary dermis in psoriatic lesions. 25 The production of IL-24 by the infiltrating monocytes in the dermis may initiate persistent activation of receptor and abnormal proliferation of keratinocytes in the epidermis. Abnormal proliferation of keratinocyte is crucial to the development of psoriasis.
We have previously screened polymorphisms in the IL-19 and IL-20 genes and identified an association between plaque-type psoriasis and extended haplotype CACCG GAA of IL-19 and IL-20 genes. 30 In the present study, we attempted to elucidate the role of the IL-24 gene in predicting risk for psoriasis and to describe the linkage disequilibrium (LD) pattern of the IL-19, IL-20 and IL-24 genes. The association and haplotype analyses of the IL-24 gene were carried out. Furthermore, we performed the extended haplotype analysis of the IL-24 polymorphisms and IL-20 polymorphism rs1518108, which was not in LD with the other polymorphisms in the IL-20 gene. No polymorphisms of the IL-24 gene have been investigated in complex diseases up to the present time.
Results
The dbSNP database (www.ncbi.nlm.nih.gov/SNP/) search was performed to find out the single-nucleotide polymorphisms (SNPs) of the IL-24 gene in an initial study. The selection criteria for SNP inclusion were the following: frequency of minor allele higher than 10% and distance between SNPs approximately 1000-2000 bp. Only validated SNPs were included in the study. The selected SNPs were rs3762344, rs291111, rs1150253, rs1150256 and rs1150258 of the IL-24 gene (Figure 1 ).
Genotype distributions of the analyzed polymorphisms of IL-24 gene were in Hardy-Weinberg equilibrium. Allele frequencies and allelic P-values of IL-24 SNPs in the plaque-type psoriasis and in different subtypes of psoriasis compared to the control group are presented in Table 1 . Comparing psoriasis patients with controls, none of the analyzed IL-24 SNPs showed statistically significant association with susceptibility to psoriasis. However, performing association analyses according to different psoriasis subtypes, the SNP rs1150253 showed statistically significant association with limited form of psoriasis (extent of body involvement p10%) relying on allelic P-value 0.02. The frequency of allele G was higher in psoriasis compared to the control group (54.4 and 42.2, respectively). Similarly, frequencies of minor alleles of SNPs rs3762344, rs1150256 and rs1150258 were higher in psoriasis patients with the extent of the eruption equal or below 10% of body involvement, but the differences were not statistically significant. The haplotype analysis of IL-24 gene was performed according to pairwise LD pattern in the pooled samples. We excluded SNP rs291111 from the haplotype analyses because the frequency of its minor allele was lower than 0.10. The pairwise LD matrix showed that the polymorphisms of the IL-24 gene were in the nearly complete LD (|D 0 | between 0.94 and 0.99). Four common haplotypes (HT1 AAAC, HT2 GGGT, HT3 GAGT and HT4 AGAC) each with the frequency X1% within IL-24 gene were revealed, and in sum, these covered 98.24% of all possible marker combinations in the pooled samples. No significant association was observed concerning these common haplotypes in susceptibility to psoriasis (Table 2 ). However, we found that the subgroup of limited eruption (extent p10%) had a higher frequency of the haplotype HT2 GGGT (P ¼ 0.05, OR 1.548, 95% CI 1.007-2.380) in comparison with the control group. The effect of rs1150253 allele G was marginally significant within the GGGT haplotypic background (P ¼ 0.05, OR 3.508, 95% CI 0.978-12.582). As the susceptibility effect of haplotype GGGT was not observed in the subgroup of patients with PASI (Psoriasis Area and Severity Index) equal or below 20 (P ¼ 0.26, OR 1.213 95% CI 0.865-1.700), this association seems not to be crucial. The determination of skin involvement only by the extent of eruption is probably insufficient for discrimination for psoriasis severity.
We demonstrated previously that the nearly complete LD (|D 0 | between 0.88 and 0.99) existed between the polymorphisms rs2981572, rs2981573 and rs2232360 within the IL-20 gene. Inversely, the IL-20 rs1518108 polymorphism, which is located in the 3 0 -end of the IL-20 gene, was not in LD with the other polymorphisms of the IL-20 gene. In the individual evaluation of IL-20 SNPs, we demonstrated that rs1518108 heterozygous genotype T/C had a protective effect against psoriasis (P ¼ 0.03). The extended haplotype analysis pointed out that the control group had a significantly higher frequency of the haplotype HT5 CAAAC compared with psoriasis patients (P ¼ 0.000186, OR 0.154, 95% CI 0.059-0.411). Similarly, the haplotype HT5 CAAAC was more frequent in the control group in comparison with the subgroup of early-onset psoriasis (P ¼ 0.000346, OR 0.121, 95% CI 0.038-0.385) and late-onset psoriasis (P ¼ 0.016721, OR 0.152, 95% CI 0.033-0.711), and also with familial (P ¼ 0.007950, OR 0.059, 95% CI 0.007-0.477) and sporadic psoriasis (P ¼ 0.001744, OR 0.179, 95% CI 0.061-0.525). The detected protective effect of the HT5 The higher frequency of other two haplotypes-HT1 TAAAC and HT2 CGGGT-in the psoriasis group was observed, but the differences compared to controls were not statistically significant. Detailed results of the haplotype analysis of the IL-24 gene and also results of the extended haplotype analysis of the IL-20 and IL-24 genes are presented in Table 2 .
The susceptibility effect of the IL-24 haplotype GGGT in the subgroup of psoriasis with the extent of eruption equal or below 10% of body involvement did not withstand after extended haplotype analysis of the IL-20 and IL-24 polymorphisms (Table 3) .
The LD analysis of the region comprising of IL-19, IL-20 and IL-24 genes revealed the existence of two haplotype blocks with a recombination site between SNPs rs2232360 and rs1518108 (Figure 2 ). The first haplotype block (30 kb) includes five SNPs across the IL-19 gene (rs2243191, rs2073186, rs2243174, rs2243188 and rs2243193) and three SNPs from the IL-20 gene (rs2981572, rs2981573 and rs2232360). The second haplotype block (31 kb) includes one SNP (rs1518108) from the IL-20 gene and four SNPs across the IL-24 gene (rs3762344, rs1150253, rs1150256 and rs1150258). Five common haplotypes were discovered within the both blocks. Within block 1, the haplotype CACCGGAA had susceptibility effect to psoriasis as we have demonstrated Role of IL-24 gene in plaque-type psoriasis S Kõks et al previously. 30 Within block 2, the three haplotypes CAAAC, TGGGT and CGAGT had protective effect to psoriasis ( Table 2) .
Discussion
The long arm of chromosome 1 has been of interest for mapping a susceptibility locus for psoriasis since the scan of one of the largest Italian pedigrees with psoriasis revealed the evidence for linkage to the 1cen-q21 markers. 32 This locus has been termed as PSORS4 susceptibility locus. Additional LD analysis with cohort of 79 Italian triads proved the association between psoriasis and markers of chromosome 1q21 lying in the region of the Epidermal Differentiation Cluster. 33 There is a cluster of IL-10 gene encoding the cytokines IL-10, IL-19, IL-20 and IL-24 on the long arm of region q31-32 of the same chromosome. 34 Three cytokines of the IL-10 gene cluster-IL-19, IL-20 and IL-24-have also been represented as IL-19 subfamily cytokines. 22 The exact biological functions of the IL-19 subfamily cytokines are still unknown, but several evidences indicate their role in the pathogenesis of psoriasis.
The overexpression of IL-20 induced lesions on transgenic mice similarly to the skin changes observed in psoriasis. The histological analysis of the skin of IL-20 transgenic mice showed hyperkeratosis, thickened epidermis and proliferation in the suprabasal layer resembling human psoriatic abnormalities. Immunohistochemical analysis of epidermal markers in transgenic mice demonstrated the expression of the differentiation and proliferation markers in the suprabasal layers, which are normally confined to the basal layer. 13 The abovedescribed changes in the skin appear to be caused by circulating IL-20, because even mice expressing the transgene in other tissues (liver) were similarly affected with described skin changes. In addition, both IL-20Ra and IL-20Rb receptor subunits are markedly upregulated in human psoriatic skin compared to normal skin. 13, 25 The upregulations of both IL-20 receptor subunit mRNAs are detected in keratinocytes as well as in endothelial cells and immune cells. These are the main cell types, which interact in the pathogenesis of psoriasis. IL-19 is the proinflammatory cytokine that is markedly elevated in psoriasis lesions and is strongly suppressed by administration of IL-4 during the improvement of psoriasis. 35 Since IL-19 shares with IL-20 the same receptor complex (type I IL-20R that is composed from IL-20Ra and IL-20Rb subunits), this indicates that IL-19 may have partially overlapping biological activities with IL-20.
Recently a potential role of IL-24 (MDA-7) as a cytokine and its involvement in the immune system has been described. IL-24 mRNA was detected in human monocytes by RT-PCR. Its expression in monocytes was upregulated by stimulation of LPS and in T cells by the activation of anti-CD3 monoclonal antibody. 36 Treatment of PBMC with IL-24 causes the induction of IL-6, IFN-g, TNF-a, IL-1b, IL-12 and GM-CSF. 37 For that reason, the IL-24 may be a member of a complex cascade of cytokines involved in inflammation. The finding that IL-24 binds to IL-20 receptor complexes (type I IL-20R that is composed from IL-20Ra and IL-20Rb subunits and type II IL-20R that is composed from IL-20Rb and IL-22R subunits) indicates that IL-24 is involved in the pathogenesis of psoriasis. Moreover, expression of IL-24 was detected in dermal infiltrate in psoriatic skin. 25 Since IL-24 together with IL-19 and IL-20 are expressed by monocytes, these cytokines could form innate immune pathways of psoriasis and play the part in the epidermal response to inflammation.
In our prior studies, we have determined the LD of IL-19 and IL-20 genes and established the extended haplotype CACCGGAA that was related to increased risk (OR 2.548) for psoriasis in the sample of unrelated patients. 30 The aim of present study was to search for additional psoriasis susceptibility loci in human IL-10 gene cluster. For mapping disease loci, we used SNP markers because of their high variability, abundance and their low mutation rate. 38 The association analysis of the IL-24 SNPs demonstrated that minor allele of IL-24 rs1150253 is the presumable risk allele in the subgroup of patients with eruption equal or below 10% of body involvement. While several reports have indicated that in the detecting of associations the determination of haplotypes might offer more power than simple measuring of individual SNPs, 39, 40 we performed the LD analysis and haplotype analysis of the four polymorphic loci of IL-24 gene. The nearly complete LD was detected between the polymorphisms within the IL-24 gene. The results of haplotype analyses of the IL-24 gene indicate that the IL-24 haplotype GGGT could be the potential risk haplotype in subgroup of psoriasis with limited eruption (OR 1.548). Nevertheless, this finding is probably not crucial because it seems that the determination of psoriasis severity only by extent of eruption is not sufficient.
According to recent understandings, a large part of the human genome consists of the haplotype blocks. 41, 42 The block-like distribution of LD has also been observed in cytokine clusters. 43, 44 According to our previous 30 and (Figure 2 ). Out of all the possible haplotypes, five common haplotypes (frequency X1%) were observed within both blocks. Estimating the haplotype-phenotype association, we identified one haplotype within block 1 as being psoriasis susceptibility haplotype (CACCGGAA) and three haplotypes within block 2 as being protective haplotypes in psoriasis susceptibility (CAAAC, CGAGT and TGGGT). Our results indicate that the common haplotypes of disease risk may be associated with common immune variations that have the role in autoimmune disease, like psoriasis, therefore confirming the common variant/common disease hypothesis in complex diseases. This hypothesis presents that complex traits have underlying genetic variants that occur with a relatively high frequency.
40,45
The importance of examining extended haplotypes of gene clusters has been clearly demonstrated in several studies. 46, 47 In an analysis of IL-20/IL-24 extended haplotypes, the susceptibility effect to psoriasis with limited eruption (extent equal or below 10%) of the IL-24 haplotype GGGT did not withstand. Nevertheless, we found that the IL-20/IL-24 extended haplotype CAAAC was associated with a significant protective effect against plaque-type psoriasis (OR 0.154). Protective effects against psoriasis were also observed with the extended haplotype TGGGT (OR 0.591) and with the extended haplotype CGAGT (OR 0.457). Our data maintained the concept of protective haplotypes in the genetics of complex diseases. The protective haplotypes of the HLA complex genes have been shown in several autoimmune diseases like diabetes, rheumatoid arthritis and systemic lupus erythematosus. [48] [49] [50] Similarly, certain HLA haplotypes have been shown to be protective in psoriasis. [51] [52] [53] The knowledge about the non-MHC protective genes in psoriasis is insufficient at the present time. However, the existence of both susceptible and protective loci in plaque-type psoriasis has been demonstrated in the chromosome 19p13. However, functional studies will be necessary to confirm the impact of the examined SNPs and haplotypes to psoriasis susceptibility.
In conclusion, we identified two haplotype blocks within the region of IL-19 subfamily genes on human chromosome 1q32. While the IL-19/IL-20 extended haplotype CACCGGAA within the first haplotype block is a significant susceptibility factor for psoriasis (previous study), then IL-20/IL-24 haplotypes CAAAC, TGGGT and CGAGT within the second block have a significant protective effect. However, family-based studies and association studies of different populations are required to confirm the impact of the genes of IL-19 subfamily in the genetic predisposition for psoriasis.
Materials and methods
We used a population identical to our previous studies for IL-19 and IL-20 gene investigations. 30, 31 The main characteristics of participants are shown in Table 4 . Unrelated patients with plaque psoriasis from the Department of Dermatology, University of Tartu were divided into subgroups according to the age of disease onset and family history of psoriasis. The age of disease onset was defined as the age at which the patient first became aware of psoriatic skin lesions. Patients with disease onset below the age of 40 years were assigned as early-onset psoriasis, while patients with the onset of disease at the age of 40 and later years were referred to as late-onset disease. Patients were considered to have familial psoriasis if they had at least one first-or seconddegree relative with psoriasis, and considered to have sporadic disease if they had no relatives with psoriasis. 55 The severity of psoriasis was quantified by the PASI. 56 The PASI scores were calculated on the basis of the degree of erythema, desquamation and infiltration of lesions combined with the surface extension. According to the PASI scores, the patients were divided into two groups-PASI equal or below 20 (n ¼ 151) and PASI above 20 (n ¼ 85). The higher PASI score represents a greater degree of psoriatic severity. Disease severity was also scored solely in terms of the extent of the skin lesions at the time of the examination. On the basis of the extent of eruption, the patients were divided into three groups: the extent equal or below 10% (n ¼ 66), the extent between 11 and 30% (n ¼ 76) and the extent above 30% (n ¼ 94) of psoriatic involvement of the body. We excluded the psoriasis patients who were treated with systemic antipsoriasis therapy at the time of the examination of the severity of psoriasis. Healthy volunteers, free from the positive family history of psoriasis, served as a control group. Individuals with a history of other dermatoses were not included in the control group. All the subjects enrolled in this study gave written informed consent for the study as indicated in the approval note by the Ethics Review Committee on Human Research of the University of Tartu. Tetraprimer ARMS-PCR 57 was applied to detect allelic variations of chosen SNPs. This method employs two primer pairs to amplify, respectively, the two different alleles of an SNP in a single PCR reaction. Either of the allele-specific amplicons is generated using one allelespecific inner primer and one not allele-specific outer primer. Outer primers are also used to generate not allele-specific control product. Sets of four primers, specific to each SNP, were designed using online program available at http://cedar.genetics.soton.ac.uk/ public_html/primer1.html. Each PCR reaction was carried out in a total volume of 20 ml, containing 100 ng of template DNA, 20 pmol of each inner primer, 2 pmol of each outer primer, 0.2 mM dNTP, 1 Â reaction buffer (75 mM Tris-HCl, pH 8.8, 20 mM (NH 4 ) 2 SO 4 , 0.01% Tween-20, 0.1 mg/ml Tartrazine, 1% sucrose; produced by Naxo, Tartu, Estonia), 0.5 U Smart-Taq DNA polymerase (also by Naxo, Tartu, Estonia). Sequences and melting temperatures of primers, annealing temperatures for specific PCR reactions and optimized concentrations of Mg 2 þ used for genotyping of SNPs are shown in Table 5 . Similar data for genotyping reactions of IL-19 and IL-20 was shown in our previous articles. 30, 31 To increase PCR reaction specificity, we applied touchdown cycles: initial denaturation at 951C for 2 min followed by 10 cycles of 1 min denaturation at 951C, annealing at 101C higher than annealing temperature (in Table 5 ) for 1 min (decreasing by 11C per cycle) and extension at 721C for 1 min. The following 25 cycles were performed at an appropriate annealing temperature, followed by the final extension at 721C for 10 min. PCR products were separated on gel electrophoresis using 2% agarose gel and were visualized by ethidium bromide staining.
The direct sequencing of incidental DNA samples was performed using ABI Genetic Analyzer 310 (Applied Biosystems, Foster City, CA, USA) for verification of the tetraprimer ARMS-PCR results and validation of the polymorphisms. The results of the tetraprimer ARMS-PCR were completely consistent with the results of direct sequencing.
Statistical analysis of the genotype-phenotype associations was performed using population genetics software package GENEPOP version 3.3. 58 For LD and haplotype analysis, the THESIAS software was used. Pairwise LD was estimated by a log-linear model and the extent of disequilibrium was expressed in terms of standardized D 0 characteristic. Haplotype analysis was performed using maximum-likelihood method for estimating simultaneously haplotype frequencies and haplotype-phenotype Role of IL-24 gene in plaque-type psoriasis S Kõks et al association as described by Tregouet et al.
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The significance level of the tests for declaring a probability value as significant was set to 0.05.
